Fresubin 2 kcal Drink by Fresenius Kabi - compact calories for fragile patients

Fresubin 2 kcal Drink sits heavy and sweet on the tongue as a nurse twists off the cap and hands the small bottle to an elderly patient whose lunch tray is still half full. The high-calorie sip is Fresenius Kabi’s quiet workhorse in clinical nutrition.

High energy in a small bottle

Fresubin 2 kcal Drink is an oral nutritional supplement providing 2 kcal per ml, meaning a 200 ml bottle contains around 400 kcal for patients who cannot meet their needs with normal food alone. Product information from Fresubin It is classified as a Food for Special Medical Purposes and is typically used under medical supervision in hospitals, nursing homes, and at home.

Product manager Dr. Anja Müller from Fresenius Kabi explains in internal training materials that the drink is designed for patients with increased energy requirements or reduced fluid tolerance, for example after surgery or in chronic disease. The formulation aims to deliver dense calories without forcing patients to drink large volumes.

Nutrient profile and flavors

According to Fresenius Kabi’s product overview, Fresubin 2 kcal Drink is available in several flavors such as vanilla, chocolate, and fruit varieties to reduce taste fatigue during longer use. Fresenius Kabi supplement range The creamy texture is deliberately smooth so that even patients with mild swallowing difficulties can handle it after individual assessment.

Each bottle typically contains protein, fat, and carbohydrates in a balanced mix, plus vitamins and trace elements, to support both energy and basic micronutrient coverage. Clinical dietitians often combine the drink with standard meals to lift overall daily intake without major menu changes.

Target patients and use cases

Fresubin 2 kcal Drink targets adults at risk of disease-related malnutrition, for example in oncology, geriatrics, or after complex surgery where appetite is low and weight loss threatens outcomes. Clinical nutrition guideline background Physicians and dietitians usually prescribe one to three bottles per day depending on individual needs.

In German hospitals and care facilities, Fresubin products are a familiar sight on bedside tables and medication trolleys. Nurses often cool the bottles or serve them over ice to make the taste more pleasant for patients who are already tired of sweet drinks.

Pricing, reimbursement, and availability

In Germany, Fresubin 2 kcal Drink is typically pharmacy-only but reimbursable when prescribed for disease-related malnutrition, according to product information shared with healthcare professionals. Public price lists from pharmacy portals indicate that packs of 4 x 200 ml are offered in the rough range of mid-single-digit euros per bottle, depending on channel and contract.

Fresenius Kabi supplies the drink to multiple European countries and further international markets through its clinical nutrition distribution network. In many systems, reimbursement depends on national rules and documented malnutrition risk, which makes nutrition screening in hospitals a practical gatekeeper for product use.

Role in Fresenius Kabi’s portfolio and stock context

Within the Fresenius SE & Co. KGaA group, Fresenius Kabi’s nutrition line, including Fresubin 2 kcal Drink, complements its infusion therapies and generic drugs and provides recurring revenue from chronic and long-term patients. Fresenius group segment overview CEO Michael Sen regularly highlights Kabi as a core earnings pillar in investor presentations.

For investors, oral nutrition products such as Fresubin 2 kcal Drink may not dominate headlines, but they add stable, defensible cash flows on top of the higher-profile hospital and generics activities; the Fresenius SE & Co. KGaA share (ISIN DE0005785604) reflects expectations for this combined healthcare portfolio on Xetra.